ABCs of Cancer Immunology: What a Practicing Oncologist Needs to Know

Gregory L. Beatty, MD, PhD, brings his insight to a comprehensive overview of cancer immunotherapy, beginning with the fundamental laws of the immune system and incorporating the challenges for immunotherapy, efforts to restore T cell immune-surveillance, checkpoint immunotherapy in melanoma and other cancers, biomarkers of cancer immunogenicity, CAR T cells in cancer and the future for cancer immunotherapy. Dr. Beatty led the first clinical study of CD40 immunotherapy for pancreas cancer, the first in-­human study of a novel inhibitor of indoleamine 2,3 deoxygenase, and is currently working to translate novel T cell adoptive therapies for pancreas cancer.